Your browser doesn't support javascript.
loading
Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
Busund, Marit; Bugge, Nora S; Braaten, Tonje; Waaseth, Marit; Rylander, Charlotta; Lund, Eiliv.
  • Busund M; Department of Community Medicine, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • Bugge NS; Department of Community Medicine, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • Braaten T; Department of Community Medicine, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • Waaseth M; Department of Pharmacy, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • Rylander C; Department of Community Medicine, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • Lund E; Department of Community Medicine, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
Int J Cancer ; 142(11): 2293-2302, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29349773

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Progestinas / Neoplasias de la Mama / Biomarcadores de Tumor / Premenopausia / Anticonceptivos Orales Combinados Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Progestinas / Neoplasias de la Mama / Biomarcadores de Tumor / Premenopausia / Anticonceptivos Orales Combinados Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article